Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

LOGAN LABORATORIES, LLC

NPI: 1720361173 · TAMPA, FL 33609 · Clinical Medical Laboratory · NPI assigned 09/22/2011

$17K
Total Medicaid Paid
10,374
Total Claims
8,792
Beneficiaries
20
Codes Billed
2018-01
First Month
2020-08
Last Month

Provider Details

Authorized OfficialMILO, WILLIAM (VP)
Parent OrganizationSURGERY CENTER HOLDINGS, INC
NPI Enumeration Date09/22/2011

Related Entities

Other providers sharing the same authorized official: MILO, WILLIAM

ProviderCityStateTotal Paid
DENVER PAIN RELIEF CENTER PC ENGLEWOOD CO $22K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 6,074 $16K
2019 3,562 $231.26
2020 738 $1K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed 3,725 3,286 $11K
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed 5,582 4,763 $1K
83992 65 45 $384.00
80354 65 45 $338.20
80373 65 45 $338.20
80365 65 45 $338.20
80362 65 45 $338.20
80346 65 45 $338.20
80348 65 45 $338.20
80356 65 45 $338.20
80372 65 45 $338.20
80361 65 45 $338.20
80359 65 45 $338.20
80358 53 33 $338.20
80349 65 45 $338.20
80353 65 45 $338.20
80324 65 45 $338.20
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 17 13 $43.34
80369 65 45 $0.00
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 22 22 $0.00